Suppr超能文献

组蛋白去乙酰化酶1在人类肿瘤细胞增殖中的作用。

Role for histone deacetylase 1 in human tumor cell proliferation.

作者信息

Senese Silvia, Zaragoza Katrin, Minardi Simone, Muradore Ivan, Ronzoni Simona, Passafaro Alfonso, Bernard Loris, Draetta Giulio F, Alcalay Myriam, Seiser Christian, Chiocca Susanna

机构信息

European Institute of Oncology, Department of Experimental Oncology, Via Ripamonti 435, 20141 Milan, Italy.

出版信息

Mol Cell Biol. 2007 Jul;27(13):4784-95. doi: 10.1128/MCB.00494-07. Epub 2007 Apr 30.

Abstract

Posttranslational modifications of core histones are central to the regulation of gene expression. Histone deacetylases (HDACs) repress transcription by deacetylating histones, and class I HDACs have a crucial role in mouse, Xenopus laevis, zebra fish, and Caenorhabditis elegans development. The role of individual class I HDACs in tumor cell proliferation was investigated using RNA interference-mediated protein knockdown. We show here that in the absence of HDAC1 cells can arrest either at the G(1) phase of the cell cycle or at the G(2)/M transition, resulting in the loss of mitotic cells, cell growth inhibition, and an increase in the percentage of apoptotic cells. On the contrary, HDAC2 knockdown showed no effect on cell proliferation unless we concurrently knocked down HDAC1. Using gene expression profiling analysis, we found that inactivation of HDAC1 affected the transcription of specific target genes involved in proliferation and apoptosis. Furthermore, HDAC2 downregulation did not cause significant changes compared to control cells, while inactivation of HDAC1, HDAC1 plus HDAC2, or HDAC3 resulted in more distinct clusters. Loss of these HDACs might impair cell cycle progression by affecting not only the transcription of specific target genes but also other biological processes. Our data support the idea that a drug targeting specific HDACs could be highly beneficial in the treatment of cancer.

摘要

核心组蛋白的翻译后修饰是基因表达调控的关键。组蛋白去乙酰化酶(HDACs)通过使组蛋白去乙酰化来抑制转录,而I类HDACs在小鼠、非洲爪蟾、斑马鱼和秀丽隐杆线虫的发育中起关键作用。使用RNA干扰介导的蛋白敲低技术研究了单个I类HDACs在肿瘤细胞增殖中的作用。我们在此表明,在缺乏HDAC1的情况下,细胞可停滞于细胞周期的G(1)期或G(2)/M转换期,导致有丝分裂细胞丢失、细胞生长抑制以及凋亡细胞百分比增加。相反,HDAC2敲低对细胞增殖无影响,除非我们同时敲低HDAC1。通过基因表达谱分析,我们发现HDAC1的失活影响了参与增殖和凋亡的特定靶基因的转录。此外,与对照细胞相比,HDAC2的下调未引起显著变化,而HDAC1、HDAC1加HDAC2或HDAC3的失活导致了更明显的聚类。这些HDACs的缺失可能不仅通过影响特定靶基因的转录,还通过影响其他生物学过程来损害细胞周期进程。我们的数据支持这样一种观点,即靶向特定HDACs的药物在癌症治疗中可能非常有益。

相似文献

1
Role for histone deacetylase 1 in human tumor cell proliferation.
Mol Cell Biol. 2007 Jul;27(13):4784-95. doi: 10.1128/MCB.00494-07. Epub 2007 Apr 30.
2
Negative and positive regulation of gene expression by mouse histone deacetylase 1.
Mol Cell Biol. 2006 Nov;26(21):7913-28. doi: 10.1128/MCB.01220-06. Epub 2006 Aug 28.
8
9
Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts.
J Rheumatol. 2009 Aug;36(8):1580-9. doi: 10.3899/jrheum.081115. Epub 2009 Jun 16.

引用本文的文献

1
M344 Suppresses Histone Deacetylase-Associated Phenotypes and Tumor Growth in Neuroblastoma.
Int J Mol Sci. 2025 Sep 1;26(17):8494. doi: 10.3390/ijms26178494.
3
Histone Deacetylase Inhibitors Promote the Anticancer Activity of Cisplatin: Mechanisms and Potential.
Pharmaceuticals (Basel). 2025 Apr 11;18(4):563. doi: 10.3390/ph18040563.
4
Mechanisms of HDACs in cancer development.
Front Immunol. 2025 Apr 7;16:1529239. doi: 10.3389/fimmu.2025.1529239. eCollection 2025.
7
Comprehensive Analysis of the Prognostic Implications and Biological Function of HDACs in Liver Hepatocellular Carcinoma.
Int J Med Sci. 2024 Oct 28;21(14):2807-2823. doi: 10.7150/ijms.97169. eCollection 2024.
8
A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway.
ACS Pharmacol Transl Sci. 2024 Aug 13;7(9):2799-2819. doi: 10.1021/acsptsci.4c00251. eCollection 2024 Sep 13.
9
HDAC1 and FOXK1 mediate EGFR-TKI resistance of non-small cell lung cancer through miR-33a silencing.
J Transl Med. 2024 Aug 28;22(1):793. doi: 10.1186/s12967-024-05563-3.
10
Attenuates Expression and Affects Alternative Splicing of a Subset of p53-Regulated Genes.
Cancers (Basel). 2024 Apr 24;16(9):1639. doi: 10.3390/cancers16091639.

本文引用的文献

1
Discovery and development of SAHA as an anticancer agent.
Oncogene. 2007 Feb 26;26(9):1351-6. doi: 10.1038/sj.onc.1210204.
2
A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity.
Genes Dev. 2006 Sep 15;20(18):2566-79. doi: 10.1101/gad.1455006.
3
Anticancer activities of histone deacetylase inhibitors.
Nat Rev Drug Discov. 2006 Sep;5(9):769-84. doi: 10.1038/nrd2133.
5
Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effects.
Cancer Res. 2005 Sep 1;65(17):7832-9. doi: 10.1158/0008-5472.CAN-04-4608.
7
Multisite protein modification and intramolecular signaling.
Oncogene. 2005 Mar 3;24(10):1653-62. doi: 10.1038/sj.onc.1208173.
8
Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors.
Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3697-702. doi: 10.1073/pnas.0500369102. Epub 2005 Feb 28.
10
GenePicker: replicate analysis of Affymetrix gene expression microarrays.
Bioinformatics. 2004 Dec 12;20(18):3670-2. doi: 10.1093/bioinformatics/bth416. Epub 2004 Jul 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验